Frutarom acquires US flavors Company Foote & Jenks. Major part of F&J sales is to customers in the pharma industry who demand advanced solutions for masking the aftertaste of active ingredients contained in their products, as well as high quality, and conformance with strict regulatory requirements.
The acquisition of F&J is Frutarom’s eighth acquisition this year and marks the continuation of carrying out our plan to expand our activity in the US market.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at office@jewishbusinessnews.com.
Thank you.
Ori Yehudai, President and CEO of Frutarom Group, said: “This is an acquisition of growing and profitable flavor activity, Frutarom’s most profitable core field. Frutarom already operates in this area and views it as an attractive field of endeavor for itself which also provides a good fit with the activity of its specialty fine ingredients division that includes activity in active ingredients with added health value for the pharma and nutraceutical industries. We see significant synergies between F&J activity and Frutarom’s flavors activity in the US, and we intend to leverage the cross-selling possibilities that this acquisition generates both by expanding the product portfolio and by broadening the customer base.”
Mr. Yehudai concluded in saying that: “We are working towards identifying and executing further strategic acquisitions of companies and operations in our fields of activity, with special focus on fast-growing markets and activities.”
